SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-19-009973
Filing Date
2019-02-26
Accepted
2019-02-26 09:01:55
Documents
70
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tv514137_10k.htm 10-K 724310
2 EXHIBIT 21.1 tv514137_ex21-1.htm EX-21.1 2743
3 EXHIBIT 23.1 tv514137_ex23-1.htm EX-23.1 3045
4 EXHIBIT 31.1 tv514137_ex31-1.htm EX-31.1 10649
5 EXHIBIT 31.2 tv514137_ex31-2.htm EX-31.2 10498
6 EXHIBIT 32.1 tv514137_ex32-1.htm EX-32.1 5100
  Complete submission text file 0001144204-19-009973.txt   7276300

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT clrb-20181231.xml EX-101.INS 2184609
8 XBRL TAXONOMY EXTENSION SCHEMA clrb-20181231.xsd EX-101.SCH 42734
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clrb-20181231_cal.xml EX-101.CAL 48702
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clrb-20181231_def.xml EX-101.DEF 324820
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20181231_lab.xml EX-101.LAB 387288
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20181231_pre.xml EX-101.PRE 372784
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36598 | Film No.: 19631763
SIC: 2834 Pharmaceutical Preparations